Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Atlanta Catheter Therapies (Chattanooga, TN) a development-stage medical device company focused on catheter technologies for vascular disease, closed a $2.9M Series A financing. Participants were not identified.

Imagen Biotech (United Kingdom) a commercial-stage biotechnology assay company focused on analysis of signal transduction pathways and target validation, closed a $40M Series A financing. Participants include SV Life Sciences, Novo Ventures and Fidelity Biosciences.

480 Biomedical (Waltham, MA) a development-stage biopharmaceutical company focused on bioresorbable scaffold for treating occlusive disease in the femoral artery, closed $15M Series A financing. Participants include Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

Sage Therapeutics (Watertown, MA) a development-stage pharmaceutical company focused on modulators of neuronal activity for schizophrenia, depression, pain and traumatic brain injury, closed a $35M Series A financing. Participants include Third Rock Ventures.

Foundation Medicine (Cambridge, MA) a development-stage diagnostic company focused on cancer genome analysis, closed a $16M Series A financing, bringing the total round to $33.5M. Participants include Kleiner Perkins Caufield & Byers, Google Ventures and Third Rock Ventures.

Advanced ICU Care (St Louis, MO) a commercial-stage Tele-ICU medical services company focused on bedside critical care, closed a $8M Series D financing. Participants include Trident Capital, Versant Ventures, Arboretum Ventures and Catalyst Capital.

Viroblock (Switzerland) a development-stage biotechnology company focused on anti-viral fabric and air filtration technology for prevention of influenza and SARS, closed a $3.6M Series C financing. Participants include StartAngels Network.

ZeaChem (Lakewood, CO) a development-stage biofuels company focused on cellulose-based biorefinery processes for producing ethanol, closed a $24M Series C financing. Participants include Birchmere Ventures, Firelake Capital, Globespan Capital Partners, Mohr Davidow Ventures, PrairieGold Venture Partners and Spring Ventures.

Phagenesis (United Kingdom) a development-stage device company focused on neurostimulation treatment for dysphagia, closed a $9.2M Series B financing. Participants have included Inventages.

Dfine (San Jose, CA) a commercial-stage medical device company focused on minimally invasive therapeutic devices used to treat pathologies of the vertebrae, closed a $25 million Series E financing. Participants include OrbiMed, Prospect Venture Partners, Split Rock Partners, BBT Capital, Highland Capital Management and Vanguard Ventures.

CV Ingenuity (Palo Alto, CA) a development-stage medical device company focused on vascular obstructions, closed a $16M Series B financing. Participants include New Enterprise Associates, BioStar Ventures, Synergy Ventures and Western Technology.

TrialReach (United Kingdom) a commercial-stage electronic health records company focused on providing a search engine, exclusive patient information and communication channels for patients and physicians, closed a $1.2M Series A financing. Participants include Amadeus Capital Partners.

simplifyMD (Alpharetta, GA) a commercial-stage electronic health records company, closed a $4.5M Series A financing. Participants include Intersouth Partners.

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...